Matthew Roe
Cardiovascular Disease · Durham, NCNPI 1053495952
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $63,842 of the $88,153 with a category attached, or 72.4%. Amgen accounts for 72.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $76,191 and has fallen 99.9% since, to $46 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $678.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$64K
- Eli Lilly$12K
- Genentech, Inc.$10K
- Ferring Pharmaceuticals Inc.$1K
- Ferring International Pharmascience Center US$352
- Astrazeneca UK Limited$205
- plus $250 from 5 others
Across 131 payments — averaging $6029.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$249K
- Astrazeneca UK Limited$235K
- Novo Nordisk AS$230K
- Janssen Research & Development, LLC$55K
- Regeneron$14K
- Sanofi-aventis U.S. LLC$7K
What the payments were for
- Consulting fees$63,84272%
- Travel & lodging$21,99125%
- Food & beverage$2,3203%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 71 | $64,050 |
| Eli Lilly | 23 | $11,750 |
| Genentech, Inc. | 7 | $10,277 |
| Ferring Pharmaceuticals Inc. | 10 | $1,270 |
| Ferring International Pharmascience Center US | 9 | $352 |
| Astrazeneca UK Limited | 2 | $205 |
| Esperion Therapeutics, Inc. | 1 | $116 |
| Novo Nordisk | 3 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Janssen Research & Development, LLC | 1 | $30 |
| AstraZeneca | 2 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$88,153 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Other cardiovascular disease in Durham
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Robert MentzDurham$489K
- Adrian HernandezDurham$409K
- Neha PagidipatiDurham$301K
- Joseph KissloDurham$283K
- Mitchell KrucoffDurham$281K
- Ankeet BhattDurham$258K
- Christopher GrangerDurham$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.